Analyst Price Targets — NVO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 12:38 pm | — | BMO Capital | $45.00 | $47.19 | TheFly | Novo Nordisk price target lowered to $45 from $57 at BMO Capital |
| January 26, 2026 2:36 pm | Evan Seigerman | BMO Capital | $57.00 | $63.80 | StreetInsider | Novo Nordisk (NVO) PT Raised to $57 at BMO Capital |
| December 10, 2025 11:16 am | — | HSBC | $54.00 | $46.36 | TheFly | Novo Nordisk price target raised to $54 from $47 at HSBC |
| December 3, 2025 11:31 am | Thibault Boutherin | Morgan Stanley | $42.00 | $47.43 | TheFly | Novo Nordisk price target lowered to $42 from $43 at Morgan Stanley |
| November 25, 2025 9:26 am | Evan Seigerman | BMO Capital | $46.00 | $44.97 | StreetInsider | Novo Nordisk (NVO) PT Lowered to $46 at BMO Capital |
| October 14, 2025 11:29 am | Evan Seigerman | BMO Capital | $55.00 | $57.50 | TheFly | Novo Nordisk price target raised to $55 from $50 at BMO Capital |
| October 1, 2025 8:03 pm | — | HSBC | $70.00 | $59.17 | TheFly | Novo Nordisk upgraded to Buy from Hold at HSBC |
| September 29, 2025 8:29 am | — | Morgan Stanley | $47.00 | $55.61 | TheFly | Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley |
| July 31, 2025 8:46 am | — | HSBC | $57.00 | $48.89 | TheFly | Novo Nordisk downgraded to Hold from Buy at HSBC |
| July 23, 2025 8:08 pm | Jailendra Singh | Truist Financial | $48.00 | $70.03 | Benzinga | What's Going On With Hims & Hers Stock Wednesday? |
Latest News for NVO
Investors have been dumping shares of Novo Nordisk amid concerns it can't keep up with Eli Lilly. Novo Nordisk is expecting sales to decline this year, potentially by double digits.
Novo Nordisk is investing $506 million to expand manufacturing capabilities in Ireland. The move will strengthen its ability to meet both current and future demand for its oral medicines, said Novo executive Kasper Bødker Mejlvang.
Bagsværd, Denmark, 2 March 2026 – The employees in Novo Nordisk A/S have completed the election of employee representatives to the Board of Directors of Novo Nordisk A/S.
As markets grapple with the U.S. and Israel joint attack on Iran, Diane King Hall turns to stock movers kicking off the new trading week. CrowdStrike's (CWRD) upgrade from Piper Sandler signals what the firm calls a "best in class" cybersecurity platform that didn't deserve a part in the software sell-off.
NVO shares plunge 21% after Lilly's Zepbound and oral orforglipron beat its key GLP-1 drugs in head-to-head obesity and diabetes studies, respectively.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for NVO.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.